Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Roncero, Josep M."'
Autor:
Pérez-García, Arianne a, b, Osca, Gemma a, Bosch-Vizcaya, Anna a, Kelleher, Nichollas a, Santos, Nazly Y. a, Rodríguez, Rocío a, González, Yolanda a, Roncero, Josep M. a, Coll, Rosa a, Serrando, Maite c, Lloveras, Natàlia a, Tuset, Esperanza a, Gallardo, David a, ⁎
Publikováno v:
In Human Immunology September 2013 74(9):1219-1224
Autor:
Bosch-Vizcaya, Anna 1, Pérez-García, Arianne 2, Brunet, Salut 3, Solano, Carlos 4, Buño, Ismael 5, Guillem, Vicent 4, Martínez-Laperche, Carolina 5, Sanz, Guillermo 6, Barrenetxea, Cristina 7, Martínez, Carmen 8, Tuset, Esperanza 1, Lloveras, Natàlia 1, Coll, Rosa 1, Guardia, Ramon 1, González, Yolanda 1, Roncero, Josep M. 1, Bustins, Anna 1, Gardella, Santiago 1, Fernández, Cristalina 1, Buch, Joan 1, Gallardo, David 1, ∗
Publikováno v:
In Biology of Blood and Marrow Transplantation 2012 18(1):100-105
Autor:
Granell, Miquel a, Urbano-Ispizua, Alvaro a, ∗, Suarez, Belén b, Rovira, Montserrat a, Fernández-Avilés, Francesc a, Martínez, Carmen a, Ortega, Mar c, Uriburu, Carla a, Gaya, Anna a, a<%2Fce%3Asup>%2E%22">Roncero, Josep M Owen A. O'Connor, Judith Trotman, Judit Demeter, Andrei R. Shustov, Hua Liu, Nelson Hamerschlak, Sheldon-Waniga E, Eric D. Hsi, Francesco d'Amore, Dolores Caballero, P. L. Zinzani
Publikováno v:
Journal of Clinical Oncology
O'Connor, O A, Özcan, M, Jacobsen, E D, Roncero, J M, Trotman, J, Demeter, J, Masszi, T, Pereira, J, Ramchandren, R, Beaven, A, Caballero, D, Horwitz, S M, Lennard, A, Turgut, M, Hamerschlak, N, d'Amore, F A, Foss, F, Kim, W-S, Leonard, J P, Zinzani, P L, Chiattone, C S, Hsi, E D, Trümper, L, Liu, H, Sheldon-Waniga, E, Ullmann, C D, Venkatakrishnan, K, Leonard, E J, Shustov, A R & Lumiere Study Investigators 2019, ' Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma ', Journal of Clinical Oncology, vol. 37, no. 8, pp. 613-623 . https://doi.org/10.1200/JCO.18.00899
O'Connor, O A, Özcan, M, Jacobsen, E D, Roncero, J M, Trotman, J, Demeter, J, Masszi, T, Pereira, J, Ramchandren, R, Beaven, A, Caballero, D, Horwitz, S M, Lennard, A, Turgut, M, Hamerschlak, N, d'Amore, F A, Foss, F, Kim, W-S, Leonard, J P, Zinzani, P L, Chiattone, C S, Hsi, E D, Trümper, L, Liu, H, Sheldon-Waniga, E, Ullmann, C D, Venkatakrishnan, K, Leonard, E J, Shustov, A R & Lumiere Study Investigators 2019, ' Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma ', Journal of Clinical Oncology, vol. 37, no. 8, pp. 613-623 . https://doi.org/10.1200/JCO.18.00899
PEREIRA, JULIANA/0000-0002-0655-2821; ZINZANI, PIER LUIGI/0000-0002-2112-2651; Trotman, Judith/0000-0001-8009-4593 WOS: 000462407900001 PubMed: 30707661 PURPOSEThe aim of this open-label, first-in-setting, randomized phase III trial was to evaluate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::798208f6ac14caadff6bb3de4243f18f
https://doi.org/10.1200/jco.18.00899
https://doi.org/10.1200/jco.18.00899